Hydrogen Research Study
← Back to Research Library
Human clinical evidenceCase ReportOther or not reported

A Gallbladder Carcinoma Patient With Pseudo-Progressive Remission After Hydrogen Inhalation.

Jibing Chen, Feng Mu, Tianyu Lu, Yangyang Ma, Duanming Du, Kecheng Xu · OncoTargets and therapy · 2019

Research-use notice

Independent study record

Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.

H2HUBB Research Library branded molecular hydrogen research image
Primary topic Cancer and Supportive Oncology Research
Evidence type Human clinical evidence
Publication type Case Report
Hydrogen method Other or not reported

H2HUBB TAKEAWAY

In this case report, tumors initially enlarged and tumor markers rose after hydrogen inhalation, followed by continued remission resembling pseudo-progression after anti-PD-1 therapy.

What the Researchers Studied

The patient was able to resume normal life two and a half months after hydrogen inhalation and survived over 10 months.

How Molecular Hydrogen Was Used

Hydrogen therapy has been reported to convert exhausted programmed cell death receptor (PD-1)+CD8+ T cells to PD-1-CD8+ T cells, in advanced colorectal cancer patients, which is associated with significantly prolonged survival.

What the Researchers Found

Hydrogen therapy has been reported to convert exhausted programmed cell death receptor (PD-1)+CD8+ T cells to PD-1-CD8+ T cells, in advanced colorectal cancer patients, which is associated with significantly prolonged survival. The tumors were initially enlarged and displayed increased tumor marker expression following hydrogen inhalation therapy, after which they continued to remit, similar to the pseudo-progression that occurs after anti-PD-1 treatment.

H₂ Mechanisms / Biological Findings

Hydrogen therapy has been reported to convert exhausted programmed cell death receptor (PD-1)+CD8+ T cells to PD-1-CD8+ T cells, in advanced colorectal cancer patients, which is associated with significantly prolonged survival.

Authors’ Conclusion

The authors concluded that this is the first report of pseudo-progression followed by sustained remission after hydrogen inhalation. This phenomenon is similar to the pseudo-progression-remission pattern that occurs following PD-1 antibody treatment. These findings suggest that hydrogen may have an inhibitory effect on PD-1 expression.